Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9670184 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL1317869 | 0.84 | ALDH1A1 (0.43) | ALDH1A1TDP1 | |
| SCHEMBL1316572 | 0.84 | ALDH1A1 (0.43) | ALDH1A1TDP1 | |
| SCHEMBL1320721 | 0.84 | ALDH1A1 (0.43) | ALDH1A1TDP1 | |
| SCHEMBL1317886 | 0.84 | ALDH1A1 (0.43) | ALDH1A1TDP1 | |
| SCHEMBL11075645 | 0.84 | ALDH1A1 (0.59) | ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL11074748 | 0.84 | ALDH1A1 (0.59) | ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL7799158 | 0.80 | PPARG (0.40) | ALDH1A1TDP1 | |
| SCHEMBL2215031 | 0.80 | PPARG (0.40) | ALDH1A1TDP1 | |
| SCHEMBL2216976 | 0.80 | PPARG (0.40) | ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0416401-B1 | Use of derivatives of phospholipides as antiviral pharmaceuticals and phospholipides | BOEHRINGER MANNHEIM GMBH (DE) | 1996-10-30 | — | — | EP | disclosed |
| US-5158942-A | PROCESS OF USING PHOSPHOLIPID DERIVATIVES TO INHIBIT MULTIPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS | BOEHRINGER MANNHEIM GMBH (DE) | 1992-10-27 | — | — | US | disclosed |
| EP-0416401-A2 | Use of derivatives of phospholipides as antiviral pharmaceuticals and phospholipides | Roche Diagnostics GmbH (DE) | 1991-03-13 | — | — | EP | disclosed |